57 Results for "

NRP1

" in MedChemExpress (MCE) Product Catalog:
Products (57)

57 Results for "NRP1" in MCE Product Catalog:

12
12 Publications Verification
Cat. No.: HY-10799
CAS No.: 1210945-69-9
Purity:  98.03%
Target:  

Complement System

Research Areas:  

Cancer

EG00229 is a neuropilin 1 (NRP1) receptor antagonist. EG00229 selectively inhibits VEGF-A binding to NRP1 b1 domain with an IC50 of 3 μM, but has no effect on VEGFA binding to VEGFR-1 and VEGFR-2 [1].
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-112151
CAS No.: 2227996-00-9
Target:  

Complement System

Research Areas:  

Cancer

EG01377 is a potent, bioavailable and selective inhibitor of neuropilin-1 (NRP1), with a Kd of 1.32 μM, and IC50s of both 609 nM for NRP1-a1 and NRP1-b1. EG01377 has antiangiogenic, antimigratory, and antitumor effects [1].
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-112151A
CAS No.: 2749438-61-5
Purity:  98.98%
Target:  

Complement System

Research Areas:  

Cancer

EG01377 dihydrochloride is a potent, bioavailable and selective inhibitor of neuropilin-1 (NRP1), with a Kd of 1.32 μM, and IC50s of 609 nM for both NRP1-a1 and NRP1-b1. EG01377 dihydrochloride has antiangiogenic, antimigratory, and antitumor effects [1].
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P70147
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: rHuNeuropilin-1, His ; Neuropilin-1, CD304; NRP1; NRPNP1; VEGF165R; BDCA4
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P1663A
ATWLPPR Peptide TFA, a heptapeptide, acts as a selective neuropilin-1 inhibitor, inhibits VEGF165 binding to NRP-1, used in the research of angiogenesis [1]. ATWLPPR Peptide TFA has potential in reducing the early retinal damage caused by diabetes .
loading...
    loading...
Cat. No.: HY-P99386
CAS No.: 1205533-60-3
Synonyms: MNRP-1685A

Research Areas:  

Cancer

Vesencumab (MNRP-1685A) is IG1 antibody against neuropilin-1 (NRP-1). Vesencumab binds to NRP-1 and prevents the subsequent coupling of NRP-1 to VEGFR-2. Vesencumab has anti-angiogenic and anti-neoplastic activities. Vesencumab can be used in the research of metastatic solid tumors, including ovarian cancer [1] .
loading...
    loading...
Cat. No.: HY-133034
CAS No.: 2569598-01-0
Purity:  99.71%
Target:  

Complement System

Research Areas:  

Cancer

NRP1 antagonist 1 (compound 12a) is a potent NRP1 antagonist with an IC50 of 19.1 μM. NRP1 antagonist 1 has the potential for cancer research [1].
loading...
    loading...
Cat. No.: HY-P3448
CAS No.: 2580154-02-3
Synonyms: CEND-1; iRGD; LSTA1
Research Areas:  

Cancer

Certepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD motif interaction with alphav-integrins and via activating NRP-1, and transforms the solid tumor microenvironment into a temporary agent conduit. Certepetide accumulates in tumors, and is used in the research of pancreatic cancer and other solid tumors [1] .
loading...
    loading...
Cat. No.: HY-P10787
CAS No.: 1354801-55-0
Target:  

Complement System

Research Areas:  

Cancer

tLyP-1 peptide is an NRP-1 targeting peptide with an IC50 of 4 μM, and its amino acid sequence is CGNKRTR. tLyP-1 peptide specifically binds to NRP-1 to target tumor cells [1].
loading...
    loading...
Cat. No.: HY-P10097
CAS No.: 329189-44-8
Target:  

VEGFR

Research Areas:  

Others

Flt2-11 is a anti-angiogenic peptide, and specifically binds NRP-1. Flt2-11 inhibits NRP-1/sVEGFR-1 interaction.
loading...
    loading...
Cat. No.: HY-RS09579
Research Areas:  

Others

NRP1 Human Pre-designed siRNA Set A contains three designed siRNAs for NRP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS16529
Research Areas:  

Others

Nrp1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Nrp1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-147762
CAS No.: 483289-96-9
Purity:  99.05%
Target:  

Complement System

Research Areas:  

Cancer

NRP1 antagonist 2 (Compound 1) is an NRP1 antagonist [1].
loading...
    loading...
Cat. No.: HY-P11286
CAS No.: 632358-46-4
Target:  

Complement System

Research Areas:  

Cancer

A7RC is a multifunctional peptide used in tumor-targeted therapy, with Cysteine added to the C-terminal of the A7R peptide (sequence: ATWLPPR). A7R (HY-P1663) is a ligand of the NRP-1 receptor, regulating intracellular signal transduction related to tumor vascularization and tumor growth [1].
loading...
    loading...
Cat. No.: HY-163062
CAS No.: 2983719-82-8
Research Areas:  

Cancer

Tubulin/NRP1-IN-1 (compound TN-2) is a dual inhibitor of Tubulin and NRP1 with IC50s of 0.71 and 0.85 μM, respectively. Tubulin/NRP1-IN-1 significantly inhibits the viability of prostate tumor cell lines and induces apoptosis [1].
loading...
    loading...
Cat. No.: HY-RS22960
Research Areas:  

Others

Nrp1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Nrp1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P3449
CAS No.: 2522933-44-2
Synonyms: TRS01
Dazdotuftide (TRS01) is a multi-target immunomodulator composed of tuftsin and phosphorylcholine-related groups. Dazdotuftide regulates TLR4/NF-κB and NRP1/VEGF165 related signaling pathways and inhibits the production of pro-inflammatory cytokines. Dazdotuftide can be used in studies related to inflammation and immunoregulation [1] .
loading...
    loading...
Cat. No.: HY-P3448S
Synonyms: CEND-1-13C6,15N2; iRGD-13C6,15N2; LSTA1-13C6,15N2
Certepetide- 13C6, 15N2 (CEND-1- 13C6, 15N2) is the 13C- and 15N-labeled Certepetide (HY-P3448). Certepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD motif interaction with alphav-integrins and via activating NRP-1, and transforms the solid tumor microenvironment into a temporary agent conduit. Certepetide accumulates in tumors, and is used in the research of pancreatic cancer and other solid tumors [1] .
loading...
    loading...
Cat. No.: HY-P10788
CAS No.: 1801552-75-9
Target:  

Complement System

Research Areas:  

Cancer

CK3 peptide is an NRP-1 targeting peptide with the amino acid sequence CLKADKAKC. The CK3 peptide specifically binds to NRP-1 to target breast cancer cells. Single-photon emission computed tomography (SPECT) and near-infrared fluorescence (NIRF) imaging show significant accumulation of CK3 peptide in xenograft tumors in nude mice. CK3 peptide can be used for molecular imaging studies of breast cancer.
loading...
    loading...
Cat. No.: HY-128446
CAS No.: 1210360-87-4
Target:  

VEGFR

Research Areas:  

Neurological Disease

CAY10781 (Compound 11) is an inhibitor of the neuropilin-1 (NRP-1) and VEGF-A interaction. CAY10781 inhibits VEGF-A-induced phosphorylation of VEGFR2 in Catecholamine A-differentiated (CAD) cells [1]< sup>.
loading...
    loading...